Syncell is a cutting-edge brand specializing in spatial proteomics technology. Led by founder and CEO Jung-Chi Liao PhD, the company has developed the revolutionary Microscoop™ technology, which can transform a regular microscope into a powerful in-cell pickable microscope. This groundbreaking technology applies an AI algorithm to selectively recover proteins and nucleic acids from specific subcellular locations, making it the world's first of its kind.

By offering the Microscoop™ technology, Syncell aims to advance the field of proteomics and contribute to solving complex biological and disease-related problems. The company was officially spun off from Academia Sinica in 2020, and since then, it has been focused on productizing and commercializing the Microscoop technology platform. Syncell prides itself on building a growth culture rooted in Silicon Valley and Taiwan, combining technology-forward thinking with an entrepreneurial and risk-taking spirit.

The company's dedicated team, with experience in renowned academic institutions such as MIT, UC Berkeley, Stanford University, and Columbia University, is passionate about creating a successful global company while upholding the highest standards of excellence. Syncell's mission is to accelerate the world's understanding of proteomics by pushing the boundaries of technology. Through their multidisciplinary team, Syncell aims to create the first and only de novo precision spatial proteomics tool.

This innovation will empower researchers to tackle previously unattainable complex biological problems and revolutionize the field of proteomics. With its dedication to excellence and passion for advancing scientific knowledge, Syncell is set to make a significant impact in the world of proteomics